Serum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes.

Serum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes.
复制标题

DOI:
10.1590/2359-3997000000288
复制
发表时间:
2017-09
影响因子:
1.7
通讯作者:
Aral, Yalcin
Aral, Yalcin
中科院分区:
医学4区
文献类型:
--
作者:
Ademoglu, Esra Nur;Gorar, Suheyla;Keskin, Muge;Carlioglu, Ayse;Ucler, Rifki;Erdamar, Husamettin;Culha, Cavit;Aral, Yalcin

文献摘要

参考文献

被引文献

相似文献

研究新诊断妊娠期糖尿病妇女妊娠24-28周时血清nesfatin-1水平,并确定nesfatin-1与几种代谢参数的相关性。 40名在妊娠24-28周时新诊断为妊娠期糖尿病的妇女和30名年龄和孕周匹配的健康孕妇被纳入这项横断面研究。采用ELISA法分析血清nesfatin-1水平,并评估nesfatin-1与几种代谢参数之间的关系。 妊娠期糖尿病患者的血清nesfatin-1水平低于对照组孕妇(p = 0.020)。多元线性回归分析显示,nesfatin-1在妊娠期糖尿病患者中较低,与孕龄、BMI、HOMA-IR、空腹血糖和年龄无关。在相关性分析中,发现与nesfatin-1具有统计学显著相关性的唯一变量是胎龄(p = 0.015,r = 0.30)。 与妊娠24-28周的对照组相比,妊娠期糖尿病妇女的nesfatin-1水平较低,这引起了人们对妊娠期糖尿病中nesfatin-1水平的关注,并激发了该领域的进一步研究。
To investigate serum nesfatin-1 levels at 24-28 weeks of pregnancy in women newly diagnosed with gestational diabetes and determine the association of nesfatin-1 with several metabolic parameters. Forty women newly diagnosed with gestational diabetes at 24-28 weeks of pregnancy and 30 healthy pregnant women matched in age and gestational week were included in this cross-sectional study. Serum nesfatin-1 levels were analyzed using ELISA, and the relationship between nesfatin-1 and several metabolic parameters were assessed. Serum nesfatin-1 levels were found to be lower in women with gestational diabetes compared to the pregnant women in the control sample (p = 0.020). Multiple linear regression analysis revealed that nesfatin-1 was lower in participants with gestational diabetes independently from gestational age, BMI, HOMA-IR, fasting plasma glucose, and age. In correlation analysis, the only variable that was found to have a statistically significant correlation with nesfatin-1 was gestational age (p = 0.015, r = 0.30). Lower nesfatin-1 levels in women with gestational diabetes compared to the control group at 24-28 weeks of gestation draws attention to nesfatin-1 levels in gestational diabetes and motivates further research in this area.
DOI: 10.1677/joe-09-0254
发表时间: 2010-03-01
影响因子: 4
作者:
Foo, Kylie S.;Brauner, Hanna;Broberger, Christian
通讯作者: Broberger, Christian
DOI: 10.1007/s12020-012-9638-7
发表时间: 2012-12-01
期刊: ENDOCRINE
影响因子: 3.7
作者:
Deniz, Rulin;Gurates, Bilgin;Gungor, Sami
通讯作者: Gungor, Sami
DOI: 10.1016/j.cyto.2012.10.029
发表时间: 2013-02-01
期刊: CYTOKINE
影响因子: 3.8
作者:
Boutsikou, Theodora;Briana, Despina D.;Malamitsi-Puchner, Ariadne
通讯作者: Malamitsi-Puchner, Ariadne
DOI: 10.12659/msm.892611
发表时间: 2015-04-04
期刊: Medical science monitor : international medical journal of experimental and clinical research
影响因子: --
作者:
Ding S;Qu W;Dang S;Xie X;Xu J;Wang Y;Jing A;Zhang C;Wang J
通讯作者: Wang J
DOI: 10.1007/s12020-011-9577-8
发表时间: 2012-06-01
期刊: ENDOCRINE
影响因子: 3.7
作者:
Aslan, Mehmet;Celik, Onder;Aydin, Suleyman
通讯作者: Aydin, Suleyman